Specialists Treating Autoimmune Muscle Diseases

who treats autoimmune muscle disease

Autoimmune muscle diseases, such as myositis and polymyositis, are characterized by the body's immune system attacking healthy muscle tissue, leading to inflammation, swelling, pain, and muscle weakness. While there is no cure for these diseases, early treatment can help manage symptoms and slow down the progression. Treatment options include immunosuppressive therapies like corticosteroids, intravenous immunoglobulin (IVIG), and plasma exchange, as well as physical therapy, speech therapy, and dietary changes. Healthcare providers, including rheumatologists, play a crucial role in diagnosing and determining the best treatment strategies for patients with autoimmune muscle diseases.

Characteristics Values
Disease Type Autoimmune muscle disease
Disease Name Myositis, Polymyositis, Dermatomyositis, Inclusion Body Myositis
Symptoms Muscle weakness, pain, trouble swallowing, difficulty talking, shortness of breath, fatigue, joint pain, stiffness, weight loss, difficulty moving, skin rashes
Diagnosis Blood tests, muscle biopsy
Treatment Immunosuppressive therapy, Corticosteroids, Intravenous immunoglobulin (IVIG), Plasma exchange, Physical therapy, Speech therapy, Diet changes, Emotional support
Treating Healthcare Provider Physician, Rheumatologist

cyvigor

Dermatomyositis

The goals of managing dermatomyositis are to treat muscle weakness, skin disease, and address any underlying complications. Treatment for dermatomyositis includes medications such as corticosteroids, prednisone, and immunosuppressive agents. The first-line treatment for muscle disease in dermatomyositis is systemic glucocorticoids with or without immunosuppressants. Initially, prednisolone is given at high doses for a few months until muscle enzyme levels decline and muscle strength improves. During this time, patients are regularly evaluated, and once an adequate response occurs, the administration of systemic steroids is gradually reduced.

Other medications used to treat dermatomyositis include azathioprine, methotrexate, mycophenolate mofetil, rituximab, and intravenous immunoglobulin (IVIg). IVIg is a purified blood product containing healthy antibodies from thousands of blood donors, which can block the damaging antibodies that attack muscles and skin. Surgery may also be an option to remove painful calcium deposits and prevent recurrent skin infections.

General measures are also important in the treatment of dermatomyositis, such as bed rest for those with severe muscle inflammation and physical therapy to prevent contractures and maintain muscle strength. Patients with dysphagia and/or gastroesophageal reflux may benefit from elevating the head of their bed and avoiding eating before bedtime to prevent aspiration pneumonitis. Additionally, sun protection is crucial, as areas affected by the dermatomyositis rash are more sensitive to the sun.

cyvigor

Polymyositis

It is important to note that polymyositis treatment depends on various factors, including symptoms, age, general health, and severity. Treatment plans may need to be adjusted over time, and some people may need a combination of treatments.

If you suspect you have polymyositis, it is important to visit a healthcare provider. They will be able to recommend the most suitable treatment plan for your specific case and help manage your symptoms.

cyvigor

Immunosuppressive therapy

Autoimmune muscle diseases are a group of diseases that cause the immune system to attack the body's muscles. These diseases include polymyositis, dermatomyositis, immune-mediated necrotizing myopathy, and inclusion body myositis. These diseases can cause muscle pain, weakness, and inflammation, and in some cases, can lead to severe, life-threatening complications.

While there is no cure for autoimmune muscle diseases, immunosuppressive therapy is often used to treat the symptoms and manage the disease. Immunosuppressive therapy aims to reduce the activity of the immune system, thereby decreasing its attack on the body's muscles. This type of therapy is often used in conjunction with other treatments, such as steroids, to help improve symptoms and slow the progression of the disease.

  • Immune-modulating drugs: These drugs help to regulate the immune system's response, reducing its activity and decreasing inflammation.
  • Corticosteroids: This class of drugs has potent anti-inflammatory properties, helping to reduce swelling and pain associated with autoimmune muscle diseases.
  • Disease-modifying anti-rheumatic drugs (DMARDs): DMARDs are commonly used to treat autoimmune diseases by slowing or stopping the immune system from attacking the body's tissues.
  • Biologic response modifiers: These medications are designed to target specific parts of the immune system, blocking the action of particular cells or proteins that are involved in the immune response.

The specific immunosuppressive medications and dosages used will depend on the type of autoimmune muscle disease being treated, the severity of the disease, and the patient's individual needs. It is important to note that immunosuppressive therapy does not cure autoimmune muscle diseases, but it can help to manage symptoms and improve the patient's quality of life.

cyvigor

Corticosteroids

Corticosteroid-induced myopathy is the most common drug-induced myopathy, with an incidence of 50% to 60% among those using corticosteroids for a prolonged period. Elderly patients are most at risk due to lower baseline muscle mass, as are patients with oncologic diseases. Corticosteroid-induced myopathy is almost always reversible, with improvement in myopathy within 3 to 4 weeks of tapering corticosteroids, although recovery can take months to a year.

It is important to note that toxicity relates to the cumulative dose of corticosteroids. Therefore, therapy should aim to find the minimum dose that will maintain the desired therapeutic effect. The risks and complications of long-term corticosteroid therapy should be discussed with the patient, and attempts should be made to lower the dose or use adjunct immunosuppression to minimise toxicity.

cyvigor

Physical therapy

One of the primary goals of physical therapy in the treatment of autoimmune diseases is to preserve joint mobility and range of motion. Physical therapists employ therapeutic exercises, manual techniques, and modalities to help patients maintain or improve their range of motion in affected joints. This can include land and water exercises, recreational, occupational, aerobic, muscle-strengthening, balance, core stability, flexibility, and daily-living exercises.

Low-intensity strength training combined with partial blood flow restriction has been found to be a safe and effective method of increasing muscle strength, function, and mass, leading to significant improvements in the quality of life of patients with autoimmune muscle diseases. Intensive home training (5 days per week for 12 weeks) has also been found to be safe and effective at increasing muscle strength and function in these patients.

Frequently asked questions

Autoimmune muscle diseases, also known as myositis, are rare diseases where the immune system attacks healthy muscle tissue, causing inflammation, swelling, pain, and eventual weakness.

Symptoms of an autoimmune muscle disease include muscle pain, trouble swallowing, difficulty talking, shortness of breath, fatigue, joint pain, stiffness, and weight loss.

Treatment for autoimmune muscle diseases includes immunosuppressive therapy, corticosteroids, intravenous immunoglobulin (IVIG), plasma exchange, and physical therapy.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment